Le laxatif prouvé en Clinique
Références :
1 Ramkumar D., Am J Gastroenterol. 2005;100:936-71.
2 L'ingrédient actif dans RelaxaMC
3 Information posologique sur RelaxaMC, Red Leaf Medical Inc., 2010

Un certain nombre d'études publiées ont été effectuées pour examiner l'efficacité et l'innocuité du polyéthylèneglycol pour la constipation.

Référence 1
Efficacy and safety of traditional medical therapies for chronic constipation: systematic review.
Rankumar D, Rao SS. Am J Gastroenterol. 2005 Apr; 100(4):936-71.
PUBMED

Other Clinical Evidence
A Randomized, Multicenter, Placebo-Controlled Trial of Polyethylene Glycol Laxative for Chronic Treatment of Chronic Constipation
Jack A. DiPalma, M.D., F.A.C.G., Mark vB. Cleveland, Ph.D., John McGowan, B.S.,
and Jorge L. Herrera, M.D., F.A.C.G. Am J Gastroenterol 2007;102:1436–1441.
PUBMED

Lactulose versus Polyethylene Glycol for Chronic Constipation.
Lee-Robichaud H, Thomas K. Morgan J, Nelson RL. Cochrane Database Syst Rev. 2010 Jul 7: (7):CD007570.
PUBMED

PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial.
Voskuijl W, de Lorijn F, Verwijs W, Hogeman P, Heijmans J, Mäkel W, Taminiau J, Benninga M. Gut. 2004 Nov;53(11):1590-4.
PUBMED

Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment.
Paré P, Bridges R, Champion MC, Ganguli SC, Gray JR, Irvine EJ, Plourde V, Poitras P, Turnbull GK, Moayyedi P, Flook N, Collins SM, Can J Gastroenterol. 2007 Apr: 21 Suppl B:3B-22B.
PUBMED

Polyethylene glycol 3350 without electrolytes for the treatment of functional constipation in infants and toddlers.
Loening-Baucke V, Krishna R, Pashankar DS.  J Pediatr Gastroenterol Nutr. 2004 Nov; 39(5):536-9.
PUBMED
© PEDIAPHARM INC. ALL RIGHTS RESERVED   l   Privacy Policy   l    Terms of Use